Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cerebral venous thrombosis in a patient with clinically isolated spinal cord syndrome.
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
Multiple sclerosis in children.
Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis.
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: A role for NK cells and M1 macrophages.
Stability of intraindividual variability as a marker of neurologic dysfunction in relapsing remitting multiple sclerosis.
Restoring nervous system structure and function using tissue engineered living scaffolds.
MS Prevalence and Patients' Characteristics in the District of Braga, Portugal.
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study.
[Multimodal complex treatment in advanced multiple sclerosis.]
The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Erythropoietin Levels in Patients with Multiple SclerosisComplicated with Anemia.
[Blood and cerebrospinal fluid test in multiple sclerosis].
Aging of the cingulum in the human brain: Preliminary study of a diffusion tensor imaging study.
Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders.
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trial.
The epidemiology of alcohol consumption and multiple sclerosis: a review.
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.
Genetically Modified Pig Models for Neurodegenerative Disorders.
Hypersensitivity Responses in the Central Nervous System.
Pages
« first
‹ previous
…
526
527
528
529
530
531
532
533
534
…
next ›
last »